CellCura ASA (FRA:C6L) ROCE % : 0.00% (As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is CellCura ASA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CellCura ASA's annualized ROCE % for the quarter that ended in Jun. 2014 was 0.00%.

CellCura ASA ROCE % Historical Data

The historical data trend for CellCura ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA ROCE % Chart

CellCura ASA Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

ROCE %

Get a 7-Day Free Trial

12.84

-46.19

-87.20

-137.33

-249.88

CellCura ASA Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
ROCE %	Get a 7-Day Free Trial															-274.86	-300.05	-1,396.40	-	-

CellCura ASA ROCE % Calculation

CellCura ASA's annualized ROCE % for the fiscal year that ended in Dec. 2013 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2013 )		(A: Dec. 2012 )		(A: Dec. 2013 )
	=	-2.705	/	( ( (4.14 - 2.068)	+	(2.392 - 2.299) )	/ 2 )
	=	-2.705	/	( (2.072	+	0.093)	/ 2 )
	=	-2.705	/	1.0825
	=	-249.88 %

CellCura ASA's ROCE % of for the quarter that ended in Jun. 2014 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2014 )		(Q: Mar. 2014 )		(Q: Jun. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2014 )		(Q: Mar. 2014 )		(Q: Jun. 2014 )
	=	-2.268	/	( ( (2.308 - 2.766)	+	(1.905 - 3.024) )	/ 2 )
	=	-2.268	/	( ( -0.458	+	-1.119 )	/ 2 )
	=	-2.268	/	-0.7885
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2014) EBIT data.

CellCura ASA (FRA:C6L) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CellCura ASA ROCE % Related Terms

Thank you for viewing the detailed overview of CellCura ASA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CellCura ASA (FRA:C6L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Unionsgata 18, Skien, NOR, 3732

Website

http://www.cellcura.com

CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines